Arca
Skip to content
Tools
Tools

Rocuronium Bromide Injection 50mg/5 mL

Recall D-0019-2022, part of FDA recall event 88841. See Piramal Critical Care, Inc.'s company page.

Piramal Critical Care, Inc. started this Class II drug recall on Sep 10, 2021 (voluntary: firm initiated); FDA lists it as terminated, terminated Sep 7, 2022.

  • Classification: Class II
  • Started: Sep 10, 2021
  • Status: Terminated

Why It Was Recalled

Class II

Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Record

Product
Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41
Quantity
100 glass vials
Lots and codes
Lot #: 20415001, 20415002, Expiration Date 05/2022
Distribution
Nationwide within the United States
Recalling firm
Piramal Critical Care, Inc., Bethlehem, PA, United States
How the firm notified
Letter
FDA classified
Oct 20, 2021

Piramal Critical Care, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.